Prognostic Value of the Standardized Uptake Value in Esophageal Cancer

• Published in: American journal of roentgenology (1976) Vol. 185; no. 2; pp. 436 - 440
• Main Authors: van Westreenen, Henderik L, Plukker, John T. M, Cobben, David C. P, Verhoogt, Carolien J. M, Groen, Henk, Jager, Pieter L
• Format: Journal Article
• Language: English
• Published: Leesburg, VA Am Roentgen Ray Soc 01.08.2005; American Roentgen Ray Society
• Subjects: Aged; Biological and medical sciences; Esophageal Neoplasms - diagnostic imaging; Esophageal Neoplasms - mortality; Esophageal Neoplasms - pathology; Esophagus; Female; Fluorodeoxyglucose F18; Gastroenterology. Liver. Pancreas. Abdomen; Humans; Investigative techniques, diagnostic techniques (general aspects); Male; Medical sciences; Middle Aged; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Survival Rate; Tumors; Radionuclide study; Nuclear medicine; Esophageal disease; Radiology; Predictive value; Digestive diseases; Malignant tumor; Positron emission tomography; Esophagus cancer; Emission tomography
• ISSN: 0361-803X; 1546-3141
• DOI: 10.2214/ajr.185.2.01850436

On PET, the level of tissue glycolysis can be quantified by the accumulation of fluorine-18-fluorodeoxyglucose expressed as the standardized uptake value (SUV). The aims of this study were to investigate the relation between SUV and the stage of disease and whether SUV can be used to predict resectability and survival in patients with esophageal cancer. SUV can be used to predict resectability; however, SUV is not an independent factor that can be used to assess survival in patients with esophageal cancer.